Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Rapid antigen tests to the rescue

covid-19.jpg
Biopanda’s COVID-19 Rapid Antigen (Ag) Test Kit provides results in 10 to 15 minutes.

Since the symptoms of COVID-19 are similar to those of other diseases, testing is the only way to know for sure if someone is infected. This is why Rapid Antigen Tests are a game-changer as they are designed to tell in a few minutes whether someone is infectious or not. This test detects protein fragments specific to the Coronavirus. It can be done in a clinic, doctor’s office, or hospital. The turnaround time for results is usually very quick, and, in some cases, results can be reported within 15 minutes.

Northern Ireland-based organisations have been quick to respond and have demonstrated the power of the region’s collaborative approach to addressing unprecedented healthcare challenges. This was demonstrated with one of the world’s first fully automated molecular diagnostic tests that can detect a SARS-CoV-2 infection in under 2.5 hours being developed in Northern Ireland.

One company that has developed several test kits to assist in the diagnosis of COVID-19 is Northern Ireland’s Biopanda Reagents. The company has worked closely with several European partners to assist in the validation of COVID-19 tests.

Philip McKee, Sales Manager, Biopanda Reagents, told Omnia Health Insights: “Biopanda Reagents’ mission statement is to provide innovative, high quality and cost-effective test reagents that offer the sensitivity, specificity and accuracy that customers require.


He explained that the Biopanda COVID-19 Rapid Antigen Test is a qualitative lateral flow immunochromatographic assay for the detection of SARS-CoV-2 antigens in nasopharyngeal (nasal) and oropharyngeal (throat) swab specimens. It is intended for use as a tool to assist in the diagnosis of SARS-CoV-2 infections, in conjunction with other tests.

On February 9, the company will be participating in the Northern Ireland: Providing innovative solutions to the world’s healthcare challengeswebinar that will highlight this innovative region's Life Sciences sector.

“At the webinar, I will be focusing on presenting our range of products and clinical tests, and highlighting our other ranges including veterinary and food safety tests,” said McKee. “I will share the success of our COVID-19 tests and the great feedback we have received from our customers. I will give an example of our customer in Bahrain.”

Philip.jpg

Philip McKee

He concluded: “I think that laboratory medicine needs to be complemented with more point-of-care diagnostic technologies and screening methods, such as what our company can provide.”

Join the webinar: Northern Ireland: Providing innovative solutions to the world’s healthcare challenges
Tuesday 9th February – 3PM GST

You can hear more from Biopanda at this webinar hosted by Invest Northern Ireland, the economic development agency for Northern Ireland, UK. With expertise across a range of specialisms, including respiratory products, diagnostics, medical devices, e-health and medtech, companies from Northern Ireland are enabling treatments that transform lives across the globe.

Register for free >>

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
catpromo_webinar
Webinars On Demand

Webinars covering everything from patient safety and diagnostics during COVID-19 to business leadership and healthcare transformation, all available to watch for free on demand. 

Hear from industry leaders like Roche Diagnostics Middle East and Beckman Coulter - or catch up on the wide range of clinical content sessions from the recent Omnia Health Live.

catpromo_webinar